SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on June 25, 2019, covering events occurring on June 21, 2019. The registrant is a Delaware corporation trading on the NASDAQ Capital Market under the symbol BSGM. The filing addresses corporate governance changes specifically regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
- Board Appointment: Samuel E. Navarro was appointed as a director effective June 21, 2019.
- Context: This appointment fills the second of two vacancies created by director resignations reported on May 17, 2019.
- Term: Mr. Navarro serves until the 2019 annual meeting of stockholders or until a successor is appointed.
Compensation and Governance Details
Mr. Navarro will receive compensation consistent with market practices and the Company's non-employee director policy. Additionally, he was granted 50,000 restricted stock units (RSUs) with the following vesting schedule:
- 50% vests on the first anniversary of his appointment.
- 50% vests on the second anniversary of his appointment.
- Vesting is contingent upon Mr. Navarro remaining a director on each vesting date.
Investor Verification Checklist
- Verify the total number of current Board vacancies and the status of the first vacancy filled prior to this appointment.
- Review the Company's non-employee director compensation policy to confirm the cash compensation amount for Mr. Navarro.
- Confirm the vesting conditions and potential dilution impact of the 50,000 RSUs granted.
- Check for any subsequent filings regarding the status of the Board composition following the May 17, 2019 resignations.